Literature DB >> 18507756

Bone marrow-derived mesenchymal stem cells are capable of mediating hepatitis B virus infection in injured tissues.

Q Rong1, L Zhang, E Su, J Li, J Li, Z Liu, Z Huang, W Ma, K Cao, J Huang.   

Abstract

UNLABELLED: We have previously showed that endothelial progenitor cells (EPCs) through uptake of hepatitis B virus (HBV) may play a critical role in mediating extrahepatic HBV diseases. However, it remains to be elucidated whether mesenchymal stem cells (MSCs) are capable of mediating HBV trans-infection into extrahepatic tissues. METHODS AND
RESULTS: In this study, we showed that HBV antigens, HBV DNA and the viral particles were detected in MSCs after 3 days virus challenge. Neither HBV covalently closed circular DNA nor pregenomic RNA were detected in MSCs. Intravenously transplantation of HBV-exposed MSCs into myocardial infarction mouse model resulted in incorporation of HBV into injured heart and other damaged tissues.
CONCLUSION: These results indicate that MSCs could serve as an additional extrahepatic virus reservoir, which may play a role at least in part in mediating HBV trans-infection into the injured tissues through the process of MSCs recruitment.
© 2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507756     DOI: 10.1111/j.1365-2893.2008.00978.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  5 in total

1.  The Human Bone Marrow Is Host to the DNAs of Several Viruses.

Authors:  Mari Toppinen; Antti Sajantila; Diogo Pratas; Klaus Hedman; Maria F Perdomo
Journal:  Front Cell Infect Microbiol       Date:  2021-04-22       Impact factor: 5.293

Review 2.  Mesenchymal Stromal Cells and Viral Infection.

Authors:  Maytawan Thanunchai; Suradej Hongeng; Arunee Thitithanyanont
Journal:  Stem Cells Int       Date:  2015-07-29       Impact factor: 5.443

3.  Biological effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro.

Authors:  Wei-Ping Zheng; Bo-Ya Zhang; Zhong-Yang Shen; Ming-Li Yin; Yi Cao; Hong-Li Song
Journal:  Mol Med Rep       Date:  2017-03-15       Impact factor: 2.952

4.  Transplantation with GXHPC1 for Liver Cirrhosis: Phase 1 Trial.

Authors:  Ko-Chang Huang; Ming-Hsi Chuang; Zung-Sheng Lin; Yi-Chun Lin; Chun-Hung Chen; Chao-Liang Chang; Pi-Chun Huang; Wan-Sin Syu; Tzyy-Wen Chiou; Zih-Han Hong; Yu-Chen Tsai; Horng-Jyh Harn; Po-Cheng Lin; Shinn-Zong Lin
Journal:  Cell Transplant       Date:  2019-11-14       Impact factor: 4.064

Review 5.  Perivascular Mesenchymal Stem/Stromal Cells, an Immune Privileged Niche for Viruses?

Authors:  Grégorie Lebeau; Franck Ah-Pine; Matthieu Daniel; Yosra Bedoui; Damien Vagner; Etienne Frumence; Philippe Gasque
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.